Literature DB >> 17537195

Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation.

E Mira1.   

Abstract

Vertigo, dizziness and imbalance are the main symptoms of vestibular disorders. They can lead to physical consequences, such as reduced postural control and falls, to psychologic/psychiatric consequences, such as anxiety-depression symptoms, panic and agoraphobia, and to cognitive defects, especially in the elderly. Consequently, the general health status and the quality of life (QoL) of vestibular patients can be significantly impaired. Several questionnaires have been developed in an attempt to quantify the degree of handicap and disability, the self-perceived health status and the quality of life in vestibular patients with dizziness and imbalance. Additionally, the main goal of the treatments of vestibular disorders should be to control symptoms, reduce functional disability and to improve patients' QoL. This article reviews the physical and psychological consequences of the vestibular disorders, their impact on the patients' QoL, and the treatment options, including drug prescriptions and vestibular rehabilitation protocols. A profile of the compound betahistine and its efficacy on QoL indices in the treatment of Menière's disease and other forms of peripheral vertigo is also presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537195     DOI: 10.1111/j.1742-1241.2006.01091.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  22 in total

Review 1.  Geriatric vestibulopathy assessment and management.

Authors:  Joseph M Furman; Yael Raz; Susan L Whitney
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

2.  Preserved otolith organ function in caspase-3-deficient mice with impaired horizontal semicircular canal function.

Authors:  Patrick A Armstrong; Scott J Wood; Naoki Shimizu; Kael Kuster; Adrian Perachio; Tomoko Makishima
Journal:  Exp Brain Res       Date:  2015-04-01       Impact factor: 1.972

3.  Histamine H1 Receptor Contributes to Vestibular Compensation.

Authors:  Zhang-Peng Chen; Xiao-Yang Zhang; Shi-Yu Peng; Zhong-Qin Yang; Yan-Bo Wang; Yang-Xun Zhang; Xi Chen; Jian-Jun Wang; Jing-Ning Zhu
Journal:  J Neurosci       Date:  2018-11-09       Impact factor: 6.167

4.  Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.

Authors:  Arne-Wulf Scholtz; Raluca Steindl; Nicole Burchardi; Irene Bognar-Steinberg; Wolfgang Baumann
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

5.  Betahistine dihydrochloride with and without early vestibular rehabilitation for the management of patients with balance disorders following head trauma: a preliminary randomized clinical trial.

Authors:  Maged B Naguib; Yasser T Madian
Journal:  J Chiropr Med       Date:  2014-03

6.  Does betahistine treatment have additional benefits to vestibular rehabilitation?

Authors:  Hale Karapolat; Nese Celebisoy; Yesim Kirazli; Cem Bilgen; Sibel Eyigor; Sercan Gode; Aycan Akyuz; Tayfun Kirazli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-21       Impact factor: 2.503

7.  Neuropharmacology of vestibular system disorders.

Authors:  Enrique Soto; Rosario Vega
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.

Authors:  A D Olusesi; S B Hassan; Y Oyeyipo; U C Ukwuije; O Oyeniran
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-26       Impact factor: 2.503

Review 9.  The impact of dizziness on quality-of-life in the elderly.

Authors:  Andrea Ciorba; Chiara Bianchini; Giovanni Scanelli; Marco Pala; Amedeo Zurlo; Claudia Aimoni
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-22       Impact factor: 2.503

Review 10.  Management of vestibular schwannoma: focus on vertigo.

Authors:  Manisha Dayal; Angelica Perez-Andujar; Cynthia Chuang; Andrew T Parsa; Igor J Barani
Journal:  CNS Oncol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.